May 7, 2026 | Blog
What if many clinical trial delays attributed to African sites begin much earlier — in weak feasibility design? When a study misses its first-patient-in date or enrolment lags, the explanation is often reduced to a familiar shorthand: “Africa is difficult.” But that...
May 4, 2026 | Blog
African trial start-up is often described as slow. It is one of the most durable assumptions in global clinical development, and one of the least examined. It appears in sponsor discussions, conference panels, and country-selection assumptions. But clinical trial...
Apr 25, 2026 | Blog
Malaria remains one of the most serious public health threats across Africa. According to the World Health Organization (WHO), there were an estimated 282 million malaria cases globally in 2024 and 610,000 malaria deaths. The WHO African Region accounted for 95% of...
Apr 23, 2026 | Blog
Africa carries a substantial share of the global disease burden but continues to host only a small proportion of global clinical trials (1). This imbalance affects where evidence is generated, whose populations are represented, and how confidently findings can be...
Apr 16, 2026 | Blog
A familiar narrative in global health frames the pharmaceutical industry and global health priorities as fundamentally opposed: one driven by profit, the other by people. It is a compelling framing, but one that is often too simplistic to be useful. The more important...
Apr 9, 2026 | Blog
Growth in African clinical research is becoming more visible. More studies are being placed, more partnerships are being announced, and regulatory systems in several countries are evolving. But beneath that momentum sits a quieter question: what determines whether...
